ARKG ETF — Holdings & Market Internals
A visuals-first look inside ARK Genomic Revolution ETF (ARKG): a weight-sized holdings treemap, sector concentration, and the breadth oscillators that reveal whether the fund's move is broad or narrow — built on the live 33-name holdings snapshot.
Historical breadth is computed against the current ARKG membership, so older values carry a degree of survivorship bias (constituents removed from the fund are excluded from past readings).
Holdings Treemap
Tile size = ETF weight, grouped by sector. Color by:
Sector Weights
Share of the fund by GICS-style sector.
Market Breadth Snapshot
How many constituents are participating in the trend. See the full internals →
Trend Alignment
Cap-weighted share of the fund by where price sits across its 20/50/200-day SMAs — 20% is in full alignment.
Valuation & Fundamentals
Sector multiples and dispersion across holdings (cap-weighted harmonic mean). Full valuation →
Valuation by Sector & Distribution
Fund P/E: 19.8 — cap-weighted harmonic mean. Green = cheaper than the fund.
By sector (cap-weighted)
Distribution across holdings
One-Month Leaders
Strongest constituents over the trailing month.
One-Month Laggards
Weakest constituents — candidates for the opportunity scan.
| ILMN | Illumina Inc | 4.42% | -22.54% | 35 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 1.62% | -23.55% | 36 |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 1.35% | -24.00% | 37 |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | 1.30% | -33.32% | 24 |
| NRIX | Nurix Therapeutics, Inc. Common stock | 2.19% | -34.60% | 27 |
| VCYT | Veracyte, Inc. | 2.30% | -43.89% | 28 |
Holdings Explorer
Top 30 by weight — sort any column. View all 33 holdings →
| TEM | Tempus AI, Inc. Class A Common Stock | Technology | 10.57% | $70.24 | -5.69% | +10.55% | +40.06% | 47 | 59 | $14.2B |
| TXG | 10x Genomics, Inc. Class A Common Stock | Industrials | 7.87% | $57.56 | -1.64% | -16.09% | +4.40% | 39 | 100 | $8.5B |
| TWST | Twist Bioscience Corporation Common Stock | Health Care | 7.56% | $110.20 | -2.30% | -19.18% | -4.54% | 38 | 100 | $9.3B |
| CRSP | CRISPR Therapeutics AG | Health Care | 5.10% | $42.33 | -0.93% | -15.52% | -20.42% | 32 | 37 | $4.8B |
| GH | Guardant Health, Inc. Common Stock | Health Care | 5.08% | $148.16 | -1.97% | -5.65% | -3.04% | 39 | 95 | $23.5B |
| ABSI | Absci Corporation Common Stock | Health Care | 5.00% | $8.52 | -7.50% | +0.24% | -8.05% | 42 | 99 | $1.7B |
| LLY | Eli Lilly & Co. | Health Care | 4.64% | $1438.82 | +0.84% | +16.88% | +22.83% | 70 | 94 | $1.26T |
| NTRA | Natera, Inc. Common Stock | Health Care | 4.60% | $318.40 | -1.12% | -18.16% | +2.77% | 34 | 95 | $56.0B |
| ILMN | Illumina Inc | Health Care | 4.42% | $207.76 | -1.16% | -22.54% | +8.38% | 35 | 97 | $36.0B |
| BEAM | Beam Therapeutics Inc. Common Stock | Health Care | 3.90% | $23.05 | -5.04% | -2.89% | -13.91% | 40 | 62 | $2.7B |
| SDGR | Schrodinger, Inc. Common Stock | Health Care | 3.77% | $29.50 | -4.28% | +20.53% | +70.10% | 54 | 96 | $2.0B |
| CDNA | CareDx, Inc. | Health Care | 3.64% | $78.26 | -2.39% | +22.22% | +71.83% | 55 | 100 | $4.6B |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | Health Care | 2.93% | $29.05 | -1.42% | +14.02% | +18.77% | 57 | 98 | $4.1B |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | Health Care | 2.76% | $3.17 | -4.50% | -12.74% | +2.08% | 40 | 34 | $2.2B |
| CMPS | COMPASS Pathways Plc American Depository Shares | Health Care | 2.71% | $8.93 | -1.10% | -19.91% | -32.71% | 38 | 96 | $1.2B |
| VCYT | Veracyte, Inc. | Health Care | 2.30% | $23.71 | -1.26% | -43.89% | -40.60% | 28 | 31 | $4.0B |
| NRIX | Nurix Therapeutics, Inc. Common stock | Health Care | 2.19% | $15.46 | -0.87% | -34.60% | -41.85% | 27 | 85 | $2.8B |
| PRME | Prime Medicine, Inc. Common Stock | Health Care | 1.98% | $4.32 | +9.38% | +36.86% | +39.09% | 52 | 70 | $825M |
| ALMR | Alamar Biosciences, Inc. Common Stock | Industrials | 1.93% | $30.77 | -2.87% | +22.55% | -6.86% | 52 | 0 | $2.1B |
| NTLA | Intellia Therapeutics, Inc | Health Care | 1.87% | $9.81 | -7.96% | -14.39% | -18.56% | 36 | 53 | $1.7B |
| BFLY | Butterfly Network, Inc. | Health Care | 1.78% | $6.00 | -10.64% | -18.93% | -30.28% | 41 | 99 | $1.7B |
| WGS | GeneDx Holdings Corp. Class A Common Stock | Health Care | 1.62% | $52.41 | +0.87% | -23.55% | -32.33% | 36 | 26 | $2.0B |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | Health Care | 1.35% | $8.37 | -1.18% | -24.00% | +1.95% | 37 | 54 | $271M |
| SCTX | Scribe Therapeutics Inc. Common Stock | Health Care | 1.31% | $16.48 | -4.47% | -21.31% | -20.51% | 43 | 0 | $332M |
| IAM | Iambic Therapeutics, Inc. Common Stock | Health Care | 1.30% | $12.82 | -12.03% | -18.89% | -- | 41 | 0 | $1.1B |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | Health Care | 1.30% | $28.92 | +6.41% | -33.32% | -49.12% | 24 | 26 | $6.7B |
| PACB | Pacific Biosciences of California, Inc. | Industrials | 1.24% | $1.93 | -0.76% | +1.55% | +70.43% | 43 | 64 | $758M |
| GENB | Generate Biomedicines, Inc. Common Stock | Health Care | 1.08% | $11.95 | -4.06% | -3.67% | -22.78% | 41 | 0 | $1.8B |
| MASS | 908 Devices Inc. Common Stock | Industrials | 1.04% | $9.72 | -0.66% | -15.67% | -4.70% | 40 | 95 | $441M |
| FRNM | Freenome, Inc. Common stock | Health Care | 0.99% | $10.41 | -1.89% | -13.82% | -9.48% | 36 | 0 | $1.4B |